FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 128 filers reported holding FLEXION THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,394,000 | -62.0% | 431,306 | 0.0% | 3.17% | -36.7% |
| Q4 2019 | $8,928,000 | +51.0% | 431,306 | 0.0% | 5.00% | +36.6% |
| Q3 2019 | $5,911,000 | +19.7% | 431,306 | +7.4% | 3.66% | +30.0% |
| Q2 2019 | $4,940,000 | -1.5% | 401,648 | 0.0% | 2.82% | -1.7% |
| Q1 2019 | $5,013,000 | +109.1% | 401,648 | +89.6% | 2.87% | +70.2% |
| Q4 2018 | $2,397,000 | -43.1% | 211,788 | -5.9% | 1.68% | -33.2% |
| Q3 2018 | $4,211,000 | -27.6% | 225,062 | 0.0% | 2.52% | -31.5% |
| Q2 2018 | $5,818,000 | +34.9% | 225,062 | +17.0% | 3.68% | +14.8% |
| Q1 2018 | $4,313,000 | -10.5% | 192,438 | 0.0% | 3.21% | -9.1% |
| Q4 2017 | $4,819,000 | +83.7% | 192,438 | +77.4% | 3.53% | +77.7% |
| Q3 2017 | $2,623,000 | – | 108,498 | – | 1.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
| MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
| Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
| Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
| CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
| Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
| SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
| AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
| Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |